Profile data is unavailable for this security.
About the company
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.
- Revenue in USD (TTM)660.91m
- Net income in USD-15.73m
- Incorporated2007
- Employees1.01k
- LocationInspire Medical Systems Inc5500 Wayzata Blvd Ste 1600GOLDEN VALLEY 55416-1237United StatesUSA
- Phone+1 (763) 957-5037
- Fax+1 (302) 655-5049
- Websitehttps://www.inspiresleep.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Envista Holdings Corp | 2.56bn | -120.40m | 3.19bn | 12.80k | -- | 0.7698 | 292.32 | 1.24 | -0.713 | -0.713 | 14.72 | 24.09 | 0.3904 | 3.89 | 6.29 | 200,226.60 | -1.83 | 1.94 | -2.15 | 2.34 | 56.35 | 57.65 | -4.70 | 5.29 | 1.93 | 5.09 | 0.2667 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
| Procept Biorobotics Corp | 156.33m | -103.37m | 3.22bn | 626.00 | -- | 12.09 | -- | 20.61 | -2.12 | -2.12 | 3.20 | 5.18 | 0.4685 | 1.81 | 4.08 | 249,722.00 | -30.98 | -- | -34.68 | -- | 53.47 | -- | -66.12 | -- | 7.44 | -- | 0.1629 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
| LivaNova PLC | 1.19bn | -31.77m | 3.36bn | 2.90k | -- | 2.75 | 199.82 | 2.84 | -0.5911 | -0.5911 | 21.89 | 22.56 | 0.4985 | 2.57 | 6.11 | 408,634.10 | -1.33 | -6.01 | -1.54 | -7.42 | 67.89 | 66.99 | -2.67 | -13.56 | 2.71 | 2.52 | 0.3383 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
| Axonics Inc | 387.14m | -15.95m | 3.44bn | 797.00 | -- | 5.49 | -- | 8.89 | -0.3134 | -0.3134 | 7.76 | 12.29 | 0.5606 | 1.20 | 8.53 | 485,744.00 | -2.31 | -12.67 | -2.52 | -13.76 | 75.25 | 70.04 | -4.12 | -29.68 | 8.04 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
| Integer Holdings Corp | 1.63bn | 98.09m | 3.82bn | 10.50k | 39.57 | 2.50 | 19.19 | 2.34 | 2.88 | 2.88 | 47.86 | 45.52 | 0.5452 | 4.91 | 4.95 | 155,494.60 | 3.28 | 3.28 | 3.53 | 3.53 | 26.54 | 26.94 | 6.01 | 6.40 | 2.01 | 3.74 | 0.4303 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
| TransMedics Group Inc | 296.92m | -10.20m | 4.28bn | 584.00 | -- | 26.78 | 3,909.76 | 14.42 | -0.335 | -0.335 | 8.96 | 4.85 | 0.5874 | 3.08 | 4.93 | 508,422.90 | -2.02 | -16.08 | -2.19 | -17.95 | 62.40 | 65.37 | -3.43 | -40.47 | 8.76 | -- | 0.7607 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
| Merit Medical Systems Inc | 1.28bn | 101.95m | 4.70bn | 6.95k | 46.34 | 3.79 | 24.09 | 3.66 | 1.74 | 1.74 | 21.96 | 21.35 | 0.64 | 2.32 | 7.32 | 184,648.80 | 5.08 | 2.45 | 5.65 | 2.77 | 46.54 | 44.50 | 7.94 | 3.91 | 4.38 | 11.61 | 0.3922 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
| Haemonetics Corporation | 1.27bn | 126.57m | 4.87bn | 3.03k | 38.79 | 5.16 | 22.13 | 3.83 | 2.47 | 2.47 | 24.80 | 18.57 | 0.6229 | 2.11 | 6.47 | 418,649.00 | 6.21 | 4.74 | 7.05 | 5.89 | 53.48 | 49.87 | 9.97 | 7.41 | 1.76 | 26.49 | 0.48 | 0.00 | 17.67 | 5.27 | 166.05 | 9.48 | 8.06 | -- |
| Inspire Medical Systems Inc | 660.91m | -15.73m | 4.99bn | 1.01k | -- | 8.46 | -- | 7.54 | -0.5374 | -0.5374 | 22.46 | 19.85 | 1.05 | 3.14 | 10.01 | 653,721.10 | -2.50 | -11.27 | -2.80 | -12.60 | 84.65 | 84.47 | -2.38 | -13.57 | 7.25 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
| Lantheus Holdings Inc | 1.37bn | 460.53m | 5.27bn | 834.00 | 11.60 | 5.57 | 10.11 | 3.86 | 6.55 | 6.55 | 19.42 | 13.64 | 0.8587 | 8.78 | 4.71 | 1,637,434.00 | 28.96 | 6.69 | 34.54 | 7.73 | 64.02 | 53.90 | 33.72 | 9.02 | 4.55 | -- | 0.3733 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
| Glaukos Corp | 326.43m | -140.87m | 5.56bn | 907.00 | -- | 12.22 | -- | 17.04 | -2.88 | -2.88 | 6.68 | 9.04 | 0.3426 | 1.72 | 7.74 | 359,905.20 | -14.78 | -8.73 | -15.91 | -9.35 | 76.18 | 74.77 | -43.16 | -28.69 | 4.68 | -38.38 | 0.4395 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Novanta Inc | 893.45m | 69.29m | 5.79bn | 2.90k | 83.93 | 8.49 | 49.43 | 6.48 | 1.92 | 1.92 | 24.77 | 18.99 | 0.6778 | 2.99 | 6.11 | 308,086.90 | 5.26 | 5.46 | 5.92 | 6.34 | 45.07 | 43.24 | 7.76 | 7.71 | 1.77 | 4.42 | 0.4319 | 0.00 | 2.41 | 7.49 | -1.58 | 8.21 | 4.19 | -- |
| DENTSPLY SIRONA Inc | 3.94bn | -95.00m | 5.79bn | 15.00k | -- | 1.78 | 22.89 | 1.47 | -0.4468 | -0.4468 | 18.69 | 15.69 | 0.5326 | 2.94 | 6.02 | 262,666.70 | -1.24 | -1.14 | -1.52 | -1.32 | 52.61 | 53.65 | -2.34 | -2.51 | 0.9692 | 3.29 | 0.3908 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
| Masimo Corp | 1.98bn | 79.10m | 6.44bn | 3.80k | 83.16 | 4.74 | 36.71 | 3.26 | 1.46 | 1.46 | 36.54 | 25.71 | 0.6507 | 2.01 | 5.24 | 519,973.70 | 2.60 | 8.65 | 3.17 | 10.31 | 48.61 | 57.30 | 4.00 | 12.03 | 1.31 | 3.61 | 0.3909 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
| Stevanato Group SpA | 1.17bn | 146.64m | 6.59bn | 5.64k | 39.46 | -- | 34.46 | 5.65 | 0.553 | 0.553 | 4.40 | -- | -- | -- | -- | 207,040.70 | -- | -- | -- | -- | 30.81 | -- | 12.57 | -- | -- | 32.91 | -- | -- | 10.34 | -- | 1.95 | -- | -- | -- |
Data as of May 13 2024. Currency figures normalised to Inspire Medical Systems Inc's reporting currency: US Dollar USD
47.59%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 2.85m | 9.63% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 2.76m | 9.32% |
| Baillie Gifford & Co.as of 31 Mar 2024 | 1.47m | 4.96% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 1.46m | 4.95% |
| Wellington Management Co. LLPas of 31 Dec 2023 | 1.43m | 4.83% |
| Wasatch Advisors, Inc.as of 31 Mar 2024 | 1.10m | 3.73% |
| Farallon Capital Management LLCas of 31 Dec 2023 | 855.10k | 2.89% |
| William Blair Investment Management LLCas of 31 Mar 2024 | 763.73k | 2.58% |
| Frontier Capital Management Co. LLCas of 31 Dec 2023 | 742.05k | 2.51% |
| Champlain Investment Partners LLCas of 31 Dec 2023 | 648.60k | 2.19% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
